Published: Guidance, quality standards and advice
Showing 1 to 2 of 2
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Encorafenib with binimetinib for treating BRAF V600E mutation-positive advanced non-small-cell lung cancer | TA1150 | ||
| Encorafenib with binimetinib for unresectable or metastatic BRAF V600 mutation-positive melanoma | TA562 |